Effect of Ivabradine, a Novel Antianginal Agent, on Driving Performance: A Randomized, Double-Blind, Placebo-Controlled Trial in Healthy Volunteers

By Macher Jean-Paul  

Clinical Drug Investigation, Vol. 29, Iss. 5, 2009-01 ,pp. : 339-348

Adis International

Access to resources Recommend Favorite

Flutamide in unresectable pancreatic adenocarcinoma: A randomized, double-blind, placebo-controlled trial

By Negi Sanjay   Agarwal Anil   Chaudhary Adarsh  

Investigational New Drugs, Vol. 24, Iss. 3, 2006-05 ,pp. : 189-194

Springer Publishing Company

Access to resources Recommend Favorite

A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression

By Hantsoo Liisa   Ward-O’Brien Deborah   Czarkowski Kathryn   Gueorguieva Ralitza   Price Lawrence   Epperson C.  

Psychopharmacology, Vol. 231, Iss. 5, 2014-03 ,pp. : 939-948

Springer Publishing Company

Access to resources Recommend Favorite

Nizatidine for prevention of weight gain with olanzapine: a double-blind placebo-controlled trial

By Cavazzoni P.   Tanaka Y.   Roychowdhury S.M.   Breier A.   Allison D.B.  

European Neuropsychopharmacology, Vol. 13, Iss. 2, 2003-03 ,pp. : 81-85

Elsevier

Access to resources Recommend Favorite

Nicergoline in the long term treatment of mild or moderate senile dementia. A multicenter double-blind, randomized, placebo-controlled trial

By Nicergoline Dementia Long Term Study Italian Group   Battaglia A.   Annoni K.   Pamparana F.   De Paolis C.   Bonura M.L.   Stekke W.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 383-383

Elsevier

Access to resources Recommend Favorite